An Australian stem cell and regenerative medicine company

February 09, 2022

New frontiers in medicine

With COVID shining a light on the importance of innovation in medicine with a focus on unmet needs, read Ross’ view on the work being done to improve the effectiveness of drugs and treatments, and to reduce their side effects: 

Read Article

January 28, 2022

Cynata breaks into the second largest pharmaceutical market in the world

CEO Dr Ross Macdonald joined ausbiz to discuss the development and the outlook for Cynata in 2022 following the receipt of a patent from Japan, the world’s second largest stem cell market. 

Read Article

January 25, 2022

A step forward for Cynata’s DFU trial

Providing hope for people with diabetic foot ulcers (DFU), Cynata’s Phase I trial of CYP‑006TK has commenced and is now open for patient enrolment: 

Read Article

January 12, 2022

Government boost for next-gen medicine

Investing in medical research projects with the potential to deliver better health outcomes to more Australians is a government priority with the Morrison government investing more than $25m through the Biomedical Translation Fund three, in cutting-edge companies including Cynata:

Read Article

December 31, 2021

Cynata and Fujifilm Cellular Dynamics sign mega deal

In big news, Cynata has inked a Manufacturing Services Agreement with Fujifilm Cellular Dynamics to manufacture and supply its Cymerus™ MSCs. Cynata CEO Dr Ross Macdonald sat down with Eddy Sunarto at Stockhead to discuss just how important this deal is for the Company

Read Article